Ability to Achieve a Good Eular Response in Patients With Moderate-to-severe Active Early Rheumatoid Arthritis Who Satisfy the New ACR/EULAR Classification Criteria Receiving Etanercept + MTX in Real World Clinical Practice in Greece
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms EARLY RA
- Sponsors Pfizer
- 16 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 14 May 2015 Planned End Date changed from 1 Apr 2015 to 1 May 2015, according to to ClinicalTrials.gov record.
- 14 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 May 2015, according to to ClinicalTrials.gov record.